U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685210) titled 'GenSci144 Tablets Phase I Clinical Trial' on June 23.
Brief Summary: This study is a Phase I single ascending dose clinical trial in which healthy adult volunteers were administered single oral doses of GenSci144 tablets at different levels. It was conducted using a randomized, double-blind, placebo-controlled design, primarily to evaluate the drug's safety and tolerability, while also exploring its pharmacokinetic and pharmacodynamic characteristics in the body, providing a basis for subsequent clinical use in the treatment of phenylketonuria.
Study Start Date: June 22
Study Type: INTERVENTIONAL
Condition:
Phenylketonuria
Inter...